Download - Financial analysis Omega Pharma
Lotte Vanmaele2 AF 4
Omega Pharma - Financial analysis
Index
•Omega Pharma
•Top brands
•Financial analysis
•Omega Pharma on the stockmarket
•Conclusion
Omega Pharma?
• Belgian Pharmaceutical Company
• Foundation: 1987 (By Marc Coucke, Yvan Vindevogel)
• Headquarter: Nazareth, Belgium
• Employees: 2.000
• Operations: 35 countries
• Euronext Brussels & BEL20 Index
• PLC
Top brands 2010
Sales: 27 m.
Sales: 33 m. Sales: 12 m.
Sales: 18 m.
Financial Analysis
Financial Analysis
Financial Analysis
2007 2008 2009
-5,000,000
0
5,000,000
10,000,000
15,000,000
20,000,000
Omega Pharma
TurnoverOperating loss, profit
Financial year
Valu
es
in €
Financial Analysis
SHORT OVERVIEW OF THE FIRST QUARTERS IN 2009 AND 2010
Quarter 1 (2010) Quarter 2 (2009) Growth %
Turnover 423,5 411,2 +3%
Operational costs 165,7 156,3 +6%
Net operating profit 33,6 39,0 -14%
Net operating earnings per share
1,44 1,67 -14%
Average number of shares 23.347.309 23.347.309 0%
Values expressed in million €
Financial Analysis
PERFORMANCE BY REGION: TURNOVER
Quarter 1 (2010) Quarter 1 (2009) Growth %
West Europe 175,8 174,9 +1%
Belgium 124,6 112,0 +11%
Growth markets (East Eur. & Turkey) 46,4 41,0 +13%
France 76,7 83,3 -8%
GROUP 423,5 411,2 +3%
Values expressed in million €
Financial Analysis - Geographical breakdown
EBITDA: : Earnings Before Interest, Taxes, Depreciation, Amortization
Emerging markets
13%
West-Eu-rope40%
Belgium28%
France19%
Turnover by region
Omega Pharma on the stockmarket
Share price evolution 1998-2010
Conclusion
•Strong company
•Large name reputation
•Strong product brands
•Sell in 35 countries
•Share prices
THE END
Thank you for watching this slidecast
Lotte Vanmaele
Sources
www.omega-pharma.be
www.nbb.be
www.wikipedia.nl